Table 3.
Significant Correlation between CPET Value and Variables.
| CPET value | Variables | ρ | p value |
|---|---|---|---|
| VE/VCO2 slope | NT-proBNP | 0.44 | 0.0015 |
| AA | -0.42 | 0.003 | |
| DGLA+AA | -0.41 | 0.0033 | |
| Alb | -0.36 | 0.0099 | |
| HbA1c | 0.33 | 0.020 | |
| DGLA | -0.22 | 0.13 | |
| EPA+DHA | -0.17 | 0.24 | |
| DHA | -0.17 | 0.24 | |
| EPA/AA | 0.12 | 0.42 | |
| EPA | -0.09 | 0.55 | |
| AA/DGLA | -0.07 | 0.61 | |
| (EPA+DHA)/AA | 0.07 | 0.63 | |
| (EPA+DHA)/(DGLA+AA) | 0.06 | 0.66 | |
| Peak VO2 | AA | 0.30 | 0.032 |
| Alb | 0.29 | 0.038 | |
| DGLA+AA | 0.26 | 0.068 | |
| (EPA+DHA)/AA | 0.23 | 0.12 | |
| (EPA+DHA)/(DGLA+AA) | 0.21 | 0.13 | |
| EPA/AA | 0.17 | 0.23 | |
| DGLA | 0.16 | 0.27 | |
| EPA | 0.03 | 0.83 | |
| AA/DGLA | -0.03 | 0.84 | |
| DHA | -0.03 | 0.85 | |
| EPA+DHA | 0.02 | 0.89 | |
| %ppVO2 | CRP | -0.40 | 0.0046 |
| NT-pro BNP | -0.33 | 0.0204 | |
| HDL-C | 0.31 | 0.0263 | |
| Alb | 0.29 | 0.041 | |
| AA | 0.23 | 0.10 | |
| DGLA+AA | 0.23 | 0.11 | |
| EPA | 0.19 | 0.18 | |
| DGLA | 0.18 | 0.21 | |
| EPA+DHA | 0.17 | 0.24 | |
| DHA | 0.13 | 0.37 | |
| EPA/AA | 0.04 | 0.78 | |
| AA/DGLA | -0.04 | 0.80 | |
| (EPA+DHA)/AA | -0.02 | 0.88 | |
| (EPA+DHA)/(DGLA+AA) | -0.02 | 0.88 |
DGLA: dihomo-γ-linolenic acid, AA: arachidonic acid, EPA: eicosapentaenoic acid, DHA: docosahexaenoic acid, NT-pro BNP: N-terminal pro-brain natriuretic peptide, HDL-C: high-density lipoprotein cholesterol, HbA1c: hemoglobin A1c, Alb: albumen, CRP: C-reactive protein, CPET: cardiopulmonary exercise test, peak VO2: peak oxygen uptake, %ppVO2: percent predicted peak VO2, VE/VCO2 slope: regression slope relating minute ventilation to carbon dioxide output